WO2004058150A3 - Anti-infectives - Google Patents

Anti-infectives Download PDF

Info

Publication number
WO2004058150A3
WO2004058150A3 PCT/US2003/040133 US0340133W WO2004058150A3 WO 2004058150 A3 WO2004058150 A3 WO 2004058150A3 US 0340133 W US0340133 W US 0340133W WO 2004058150 A3 WO2004058150 A3 WO 2004058150A3
Authority
WO
WIPO (PCT)
Prior art keywords
infectives
disclosed
formula
making
methods
Prior art date
Application number
PCT/US2003/040133
Other languages
French (fr)
Other versions
WO2004058150A2 (en
Inventor
Duke M Fitch
Original Assignee
Smithkline Beecham Corp
Duke M Fitch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Duke M Fitch filed Critical Smithkline Beecham Corp
Priority to AU2003297235A priority Critical patent/AU2003297235A1/en
Publication of WO2004058150A2 publication Critical patent/WO2004058150A2/en
Publication of WO2004058150A3 publication Critical patent/WO2004058150A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

Compounds useful as HCV anti-infectives having the formula (I) wherein the formula variables are as defined herein, are disclosed. Also disclosed are methods of making and using the same.
PCT/US2003/040133 2002-12-17 2003-12-11 Anti-infectives WO2004058150A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003297235A AU2003297235A1 (en) 2002-12-17 2003-12-11 Anti-infectives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43422702P 2002-12-17 2002-12-17
US60/434,227 2002-12-17

Publications (2)

Publication Number Publication Date
WO2004058150A2 WO2004058150A2 (en) 2004-07-15
WO2004058150A3 true WO2004058150A3 (en) 2006-03-30

Family

ID=32682012

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/040133 WO2004058150A2 (en) 2002-12-17 2003-12-11 Anti-infectives

Country Status (2)

Country Link
AU (1) AU2003297235A1 (en)
WO (1) WO2004058150A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7902203B2 (en) * 2002-11-01 2011-03-08 Abbott Laboratories, Inc. Anti-infective agents
US7378414B2 (en) 2003-08-25 2008-05-27 Abbott Laboratories Anti-infective agents
RU2007110531A (en) 2004-08-23 2008-09-27 Ф.Хоффманн-Ля Рош Аг (Ch) HETEROCYCLIC ANTIVIRAL COMPOUNDS
ES2314749T3 (en) 2004-12-21 2009-03-16 F. Hoffmann-La Roche Ag DERIVATIVES OF TETRALINA AND INDANO AND USES OF THE SAME AS 5-HT ANTAGONISTS.
WO2006093801A1 (en) 2005-02-25 2006-09-08 Abbott Laboratories Thiadiazine derivatives useful as anti-infective agents
EP1879885A1 (en) 2005-05-04 2008-01-23 F. Hoffmann-Roche AG Heterocyclic antiviral compounds
WO2007051735A1 (en) 2005-11-03 2007-05-10 F. Hoffmann-La Roche Ag Arylsulfonylchromans as 5-ht6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors
DE602007011213D1 (en) 2006-02-17 2011-01-27 Hoffmann La Roche HETEROCYCLIC ANTIVIRAL COMPOUNDS
MX2008015510A (en) 2006-06-20 2008-12-18 Hoffmann La Roche Arylsulfonamidyl tetralin derivatives and uses thereof.
KR101060451B1 (en) 2006-06-20 2011-08-29 에프. 호프만-라 로슈 아게 Arylsulfonyl naphthalene derivatives and uses thereof
WO2007147771A2 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
CN101573370B (en) 2006-10-10 2013-09-11 美迪维尔公司 HCV nucleoside inhibitor
KR20110122874A (en) 2009-03-06 2011-11-11 에프. 호프만-라 로슈 아게 Heterocyclic antiviral compounds
SG175774A1 (en) 2009-04-25 2011-12-29 Hoffmann La Roche Heterocyclic antiviral compounds
TW201103545A (en) 2009-06-24 2011-02-01 Hoffmann La Roche Heterocyclic antiviral compound
AU2010297290A1 (en) 2009-09-21 2012-03-15 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
WO2011061243A1 (en) 2009-11-21 2011-05-26 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHOO Q L ET AL: "ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL HEPATITIS GENOME.", SCIENCE., vol. 244, 1989, pages 359 - 362, XP001093889 *

Also Published As

Publication number Publication date
AU2003297235A1 (en) 2004-07-22
AU2003297235A8 (en) 2004-07-22
WO2004058150A2 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
MXPA03011329A (en) Novel anti-infectives.
WO2003059356A3 (en) Novel anti-infectives
WO2004052313A3 (en) Anti-infectives
WO2004058150A3 (en) Anti-infectives
WO2004018451A8 (en) Pyridazinone-derivatives as pde4 inhibitors
WO2003035617A3 (en) Derivatives of uk-2a
WO2005021497A3 (en) Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones
WO1999064047A8 (en) Novel antiviral compounds
AU2003222544A1 (en) Homing process
AU2003262747A1 (en) Compounds, compositions, and methods
AU2003236527A1 (en) Compounds, compositions, and methods
AU2003265242A1 (en) Compounds, compositions, and methods
AU2003270015A1 (en) Compounds, compositions, and methods
IL158485A (en) Spiropyrazole compounds
WO2003037262A3 (en) Novel anit-infectives
EP1283235A3 (en) Composition, method of making, and method of using adhesive composition
WO2004052312A3 (en) Anti-infectives
WO2004035800A3 (en) Intermediate cefdinir salts
AU2003288023A1 (en) Process for the manufacture of 1,2-epoxy-3-chloropropane
AU2001292320A1 (en) Benzylamine compound, process for producing the same, and intermediate therefor
EP1671948A4 (en) Cinnamoyl compound and use of the same
AU2003277079A1 (en) Compounds, compositions, and methods
WO2005005382A3 (en) Compounds, compositions and methods
EP1671961A4 (en) Cinnamoyl compound and use of the same
WO2005061496A8 (en) Aminopyridine-derivatives as inductible no-synthase inhibitors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AU BA BB BR BZ CA CN CO CR CU DM DZ EC EG GD GE HR ID IL IN IS JP KP KR LC LK LR LT LV MA MG MK MN MX NO NZ OM PH PL RO SC SG TN TT UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP